MedPath

A clinical study to see the effect of some Ayurvedic formulation in the treatment of near sightedness.

Phase 2
Not yet recruiting
Conditions
Myopia. Ayurveda Condition: TIMIRAH,
Registration Number
CTRI/2023/05/053219
Lead Sponsor
SANE GURUJI AROGYA KENDRA
Brief Summary

The visual disturbance is represented as one of the complex problem in the field of ophthalmology. Myopia is refractive error in which parallel rays of light from an infinity enters the eye and is focused in front of retina, when accommodation is at rest. The progress of the disease myopia causes gradual loss of vision and sometime it causes severe visual impairment. In modern science the treatment for myopia is use of eyeglasses, contact lens, laser assisted in situ keratomileusis(LASIK), laser-assisted sub epithelial keratectomy(LASEK), refractive keratometry. In Ayurveda, when the vitiated Doshas invades Patala, the patient complains about the symptoms of disease i.e. difficulty to see distant object or blurred vision. etc. and if untreated it shifts to next Patala. But according to Ayurvedic Samhita, Prathama-Dwitiya Patalagata Timira is Aushdha Sadhya Vyadhi. modern techniques i.e. refractive surgeries for treatment for myopia are costly hence the Ayurvedic science is better alternative for this condition. The oral administration of Chitrakadi Kwatha is an easy and feasible procedure. It is also affordable to patient. It prevents pathology of Timira. Dravyas includes in yoga includes are Chitrakmula, Triphala, Patol, Yava and Ghrita. Oral administration of Chitrakadi Kwatha which is said by Acharya Vangasen is selected for study. Purpose of study is found out solution for Prathama Dwitiya Patalagata Timira

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
34
Inclusion Criteria
    1. Patient Enrolled with symptoms of Prathama-Dwitiya Patalagata Timira i.e. Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of blurriness), Dooramnekshate (difficulty of distant vision) in Shalakya OPD.
    1. Age-18 to 40 years.
    1. Patient who have <-3D refractive index in the eyes.
    1. Patient of either gender.
    1. Patient having visual acuity of 6/12, 6/18, 6/24, 6/36, 6/60, or less than 6/60 in the eyes.
    1. Patient who ready to give consent.
Exclusion Criteria
    1. Patient who have symptoms of Tritiya and Chaturtha Patalagata Timira will be excluded.
    1. Congenital type of myopia, pathological type of myopia, acquired or secondary type of myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced, post keratitis.
  • will be excluded.
    1. Myopia associated with other ocular diseases like cataract, glaucoma, etc.
    1. Patient who have myopia associated with other refractive errors such as astigmatism, presbyopia.
    1. Patient who have known case of hypertension, diabetes mellitus, Rheumatic arthritis or any other arthritic conditions, rheumatic heart disease, thyroid disorder, asthma, Koch’s, HIV will be excluded.
    1. Patient who have active infectious diseases i.e. viral, fungal, bacterial conjunctivitis, trachoma, blepharitis.
    1. Patient below 18 years and above 40 years will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms like Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of bluriness), Dooramnekshate (difficulty of distant vision) will be decreased and relief from myopia.Follow of will be taken on 7th, 15th day and symptoms will be noted of before and after treatment.
Secondary Outcome Measures
NameTimeMethod
Improvement in visual acuity of patient, decrease in severity and duration of symptoms18months.

Trial Locations

Locations (1)

SANE GURUJI AROGYA KENDRA, MALWADI ROAD, HADAPSAR.

🇮🇳

Pune, MAHARASHTRA, India

SANE GURUJI AROGYA KENDRA, MALWADI ROAD, HADAPSAR.
🇮🇳Pune, MAHARASHTRA, India
DR SHIVRAJ SHRIRAM VANSURE
Principal investigator
7304902999
shivrajvansure20@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.